Top

Published in:

Open Access 01-12-2010 | Review

Management of osteoporosis in patients hospitalized for hip fractures

Authors: T. P. Ip, J. Leung, A. W. C. Kung

Published in: Osteoporosis International | Special Issue 4/2010

Abstract

Hip fracture is associated with high morbidity, mortality, and economic burden worldwide. It is also a major risk factor for a subsequent fracture. A literature search on the management of osteoporosis in patients with hip fracture was performed on the Medline database. Only one clinical drug trial was conducted in patients with a recent hip fracture. Further studies that specifically address post-fracture management of hip fracture are needed. The efficacy of anti-osteoporosis medication in older individuals and those at high risk of fall is reviewed in this paper. Adequate nutrition is vital for bone health and to prevent falls, especially in malnourished patients. Protein, calcium, and vitamin D supplementation is associated with increased hip BMD and a reduction in falls. Fall prevention, exercise, and balance training incorporated in a comprehensive rehabilitation program are essential to improve functional disability and survival. Exclusion of secondary causes of osteoporosis and treatment of coexistent medical conditions are also vital. Such a multidisciplinary team approach to the management of hip fracture patients is associated with a better clinical outcome. Although hip fracture is the most serious of all fractures, osteoporosis management should be prioritized to prevent deterioration of health and occurrence of further fracture.

Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137(9):1001–1005PubMed

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. Bone Miner Res 15(4):721–739CrossRef

Couris CM, Duclos A, Rabilloud M, Couray-Targe S, Ecochard R, Delmas PD, Schott AM (2007) A seventy percent overestimation of the burden of hip fractures in women aged 85 and over. Bone 41(5):896–900CrossRefPubMed

Cumming RG (1996) Nursing home residence and risk of hip fracture. Am J Epidemiol 143(12):1191–1194PubMed

Brennan nee Saunders J, Johansen A, Butler J, Stone M, Richmond P, Jones S, Lyons RA (2003) Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporos Int 14(6):515–519CrossRefPubMed

Ooms ME, Vlasman P, Lips P, Nauta J, Bouter LM et al (1994) The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int 4(1):6–10CrossRefPubMed

Norton R, Campbell AJ, Reid IR, Butler M, Currie R, Robinson E, Gray H (1999) Residential status and risk of hip fracture. Age Ageing 28(2):135–139CrossRefPubMed

Butler M, Norton R, Lee-Joe T, Cheng A, Campbell AJ (1996) The risks of hip fracture in older people from private homes and institutions. Age Ageing 25(5):381–385CrossRefPubMed

Papaioannou A, Wiktorowicz M, Adachi JD, Goeree R, Papadimitropoulos E et al (2000) Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians. J Soc Obstet Gynaecol Can 22:591–597

10.

Berry SD, Samelson EJ, Ngo L, Bordes M, Broe KE, Kiel DP (2008) Subsequent fracture in nursing home residents with a hip fracture: a competing risks approach. J Am Geriatr Soc 56(10):1887–1892CrossRefPubMed

11.

Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H, Vuori I, Järvinen M (1999) Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65(3):183–187CrossRefPubMed

12.

Cooper C, Atkinson EJ, O'Fallon WM et al (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7:221–227CrossRefPubMed

13.

Bergman H, Ferrucci L, Guralnik J et al (2007) Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci 62:731–737PubMed

14.

NOF's Clinician's Guide to Prevention and Treatment Osteporosis. ww.nof.org

15.

Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M, National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62(2):105–108CrossRefPubMed

16.

Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. Bone Joint Surg Am 90(10):2142–2148CrossRef

17.

Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ (2010) Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc 58:650–657CrossRefPubMed

18.

Olofsson B, Stenvall M, Lundstrom M et al (2007) Malnutrition in hip fracture patients: an intervention study. J Clin Nurs 16:2027–2038CrossRefPubMed

19.

Salminen H, Saaf M, Johansson SE et al (2006) Nutritional status, as determined by the mini-nutritional assessment, and osteoporosis: a cross-sectional study of an elderly female population. Eur J Clin Nutr 60:486–493CrossRefPubMed

20.

Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA (2009) Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr 90(6):1674–1692CrossRefPubMed

21.

Peters BS, Martini LA (2010) Nutritional aspects of the prevention and treatment of osteoporosis. Arq Bras Endocrinol Metabol 54(2):179–185PubMed

22.

Misra D, Berry SD, Broe KE, McLean RR, Cupples LA, Tucker KL, Kiel DP, Hannan MT (2010) Does dietary protein reduce hip fracture risk in elders? The Framingham osteoporosis study. Osteoporos Int. doi:10.1007/s00198-010-1179-4 PubMed

23.

Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD (1982) Vitamin D and bone health in the elderly. Am J Clin Nutr 36:1014–1031PubMed

24.

Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729–736CrossRefPubMed

25.

Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O'Fallon WM, Khosla S (2000) Relationship of intestinal calcium absorption to 1, 25-dihydroxyvitamin D [1, 25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1, 25(OH)2D action. J Clin Endocrinol Metab 85:4023–4027CrossRefPubMed

26.

Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:447–450CrossRef

27.

Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716CrossRefPubMed

28.

Finch S, Doyle W, Lowe C, Bates CJ, Prentice A, Smithers G, Clarke PC (1998) National diet and nutrition survey: people aged 65 years and over. volume 1: report of the diet and nutrition survey. The Stationary Office, London

29.

Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA (2008) Serum 25-hydroxyvitamin D status of the US population:1988–1994 compared with 2000–2004. Am J Clin Nutr 88:1519–1527CrossRefPubMed

30.

Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Tang X, Chen Y, Lin X (2009) Diab Care 32(7):1278–1283CrossRef

31.

Wat WZ, Leung JY, Tam S, Kung AW (2007) Prevalence and impact of vitamin D insufficiency in southern Chinese adults. Ann Nutr Metab 51(1):59–64CrossRefPubMed

32.

Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642CrossRefPubMed

33.

Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis RM, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ (2005) Randomized controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330(7498):1003–1006CrossRefPubMed

34.

Brant AM, Avenell A, Campbell MK, McDonald AM, Maclenan GS, McPherosn GC et al (2005) Oral vitamin D3 and calcium for secondary prevention of low- trauma fractures in elderly people (Randomized Evaluation of Calcium Or Vitamin D, RECORD) a randomized placebo-controlled trial. Lancet 365(9471):1621–1628CrossRef

35.

Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354(7):669–683CrossRefPubMed

36.

Tang BMP, Eslick GD, Nowsan C, Smith C, Tang BMP, Eslick GD, Nowsan C, Smith C, Bensoussan (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta –analysis. Lancet 370:657–666CrossRefPubMed

37.

Avenell A, Gillespie W, Gillespie L, O'Connell D (2009) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and postmenopausal osteoporosis. Cochrane Database Syst Rev 2(2):CD000227PubMed

38.

Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haemtjens P (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415–1423CrossRefPubMed

39.

Bischoff-Ferrari HA, Willet WC, Wong JB, Stuck AE, Staehelim HB, Oray JE, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency, a meta-analysis of randomized controlled trials. Arch Intern Med 169(6):551–561CrossRefPubMed

40.

Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB, O'Reilly E, Kiel DP, Willett WC (2007) Calcium intake and hip fracture risk in men and women: a metaanalysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 86:1780–1790PubMed

41.

Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid I (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262–266CrossRefPubMed

42.

Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H, Vuori I, Jarvinen M (1999) Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65(3):183–187CrossRefPubMed

43.

Youm T, Koval KJ, Kummer FJ, Zuckerman JD (1999) Do all hip fractures result from a fall? Am J Orthop 28(3):190–194PubMed

44.

Mosekilde L (2005) Vitamin D and the elderly. Clin Endocrinol 62:265–281CrossRef

45.

Venning G (2005) Recent developments in vitamin D deficiency and muscle weakness among elderly people. Br Med J 330:524–526CrossRef

46.

Visser M, Deeg DJ, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 88:5766–5772CrossRefPubMed

47.

Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 y. Am J Clin Nutr 80:752–758PubMed

48.

Kuchuk NO, Pluijm SMF, Schoor NM, Looman CWN, Smit JH, Lips P (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94:1244–1250CrossRefPubMed

49.

Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980–2985CrossRefPubMed

50.

Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194CrossRefPubMed

51.

Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH (2009) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. Issue 2:CD007146

52.

Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin NB, Orav JE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. Br Med J 339:b3692CrossRef

53.

Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community randomised double blind controlled trial. Br Med J 326:469–472CrossRef

54.

Smith H, Anderson F, Raphael H, Crozier S, Cooper C (2004) Effect of annual intramuscular vitamin D supplementation on fracture risk: population-based, randomised, double blind, placebo-controlled trial. Osteoporos Int 15(suppl 1):S8

55.

Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz YD, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815–1822CrossRefPubMed

56.

Sato Y, Manabe S, Kuno H, Oizumi K (1999) Amelioration of osteopenia and hypovitaminosis D by 1-alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 66:64–68CrossRefPubMed

57.

Shiraki M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2 years' treatment of osteoporosis with 1alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43(2):211–220CrossRef

58.

North American Menopause Society (2010) Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17:242–255CrossRef

59.

Cranney A, Tugwell P, Zytaruk N et al (2002) Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23:540–551CrossRefPubMed

60.

Lyles KW, Colón-Emeric CS, Magaziner JS et al (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:1799–1809CrossRefPubMed

61.

Colón-Emeric CS, Mesenbrink P, Lyles KW et al (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25:91–97CrossRefPubMed

62.

Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822CrossRefPubMed

63.

Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52:1832–1839CrossRefPubMed

64.

Ensrud KE, Black DM, Palermo L et al (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the fracture intervention trial. Arch Intern Med 157:2617–2624CrossRefPubMed

65.

Seeman E, Vellas B, Benhamou C et al (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21:1113–1120CrossRefPubMed

66.

Reginster JY, Seeman E, De Vernejoul MC et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822CrossRefPubMed

67.

Boonen S, Marin F, Mellstrom D, Xie L, Desaiah D, Krege JH, Rosen CJ (2006) Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 54:782–789CrossRefPubMed

68.

Cranney A, Tugwell P, Zytaruk N (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IV Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis Endocr Rev 23:524–528

69.

Silverman SL, Christiansen C, Genant HK et al (2008) Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active controlled clinical trial. J Bone Miner Res 23:1923–1934CrossRefPubMed

70.

Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765CrossRefPubMed

71.

McDonald MM, Schindeler A, Little DG (2007) Bisphosphonate treatment and fracture repair. BoneKEy-Osteovision 4:236–251

72.

Cao Y, Mori S, Mashiba T et al (2002) Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 17:2237–2246CrossRefPubMed

73.

Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML (2009) Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am 34:595–602CrossRefPubMed

74.

Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Einhorn TA (2005) Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J Bone Joint Surg Am 87:731–741CrossRefPubMed

75.

Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 17:2038–2047CrossRefPubMed

76.

Andreassen TT, Ejersted C, Oxlund H (1999) Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960–968CrossRefPubMed

77.

Li YF, Luo E, Feng G, Zhu SS, Li JH, Hu J (2009) Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int. doi:10.1007/s00198-009-1140-6

78.

Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1–34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86:82–89CrossRefPubMed

79.

Goldhahn J, Little D, Mitchell P et al (2010) Evidence for anti-osteoporosis therapy in acute fracture situations - recommendations of a multidisciplinary workshop of the international society for fracture repair. Bone 46:267–271CrossRefPubMed

80.

Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305CrossRefPubMed

81.

Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023–1031CrossRefPubMed

82.

Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95:1174–1181CrossRefPubMed

83.

Khosla S, Amin S, Orwoll E (2008) Osteoporosis in men. Endocr Rev 29:441–464CrossRefPubMed

84.

Neuman MD, Archan S, Karlawish JH, Schwartz JS, Fleisher LA (2009) The relationship between short-term mortality and quality of care for hip fracture: a meta-analysis of clinical pathways for hip fracture. Am Geriatr Soc 57(11):2046–2054CrossRef

85.

Bruyere O, Brandi ML, Burlet N, Harvey N, Lyritis G, Minne H, Boonen S, Reginster JY, Rizzoli R, Akesson K (2008) Post-fracture management of patients with hip fracture: a perspective. Curr Med Res Opin 24(10):2841–2851CrossRefPubMed

86.

Fried LP, Tangen CM, Walston J et al (2001) Cardiovascular health study collaborative research group. J Gerontol A Biol Sci Med Sci 56:M146–M156PubMed

87.

Moayyeri A (2008) The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research. Ann Epidemiol 18(11):827–835CrossRefPubMed

88.

Li F, Harmer P, Fisher KJ et al (2005) Tai Chi and fall reductions in older adults: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 60:187–194PubMed

89.

Robertson MC, Campbell AJ, Gardner MM et al (2002) Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc 50:905–911CrossRefPubMed

90.

Verschueren SM, Roelants M, Delecluse C et al (2004) Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res 19:352–359CrossRefPubMed

91.

Parker MJ, Gillespie WJ, Gillespie LD (2005) Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 3:CD001255PubMed

92.

Parker MJ, Gillespie WJ, Gillespie LD (2006) Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 332:571–574CrossRefPubMed

Title: Management of osteoporosis in patients hospitalized for hip fractures
Authors: T. P. Ip
J. Leung
A. W. C. Kung
Publication date: 01-12-2010
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue Special Issue 4/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-010-1398-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Management of osteoporosis in patients hospitalized for hip fractures

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 4/2010

Co-managed care for fragility hip fractures (Rochester model)

Hip fracture audit: the Nottingham experience

Ortho-geriatric service—a literature review comparing different models

Outcome in geriatric fracture patients and how it can be improved

Venous thromboembolic prophylaxis for hip fractures

Geriatric hip fracture clinical pathway: the Hong Kong experience